February 27, (THEWILL) — Neimeth International Pharmaceuticals Plc has announced plans to convene a court-ordered meeting of its shareholders to consider and approve a proposed ₦1.9 billion share transfer arrangement.
The meeting, scheduled in compliance with a directive of the Federal High Court, will provide shareholders the opportunity to deliberate on and vote on the proposed restructuring initiative, which forms part of the company’s broader strategic and capital realignment plan.
According to the notice issued by the pharmaceutical firm, the proposed share transfer is designed to strengthen its ownership structure, improve financial stability, and position the company for sustainable growth. The arrangement, once approved by shareholders and sanctioned by the court, will become binding on all stakeholders.
The company said it will share detailed information about the terms of the transfer, including the rationale and expected impact on operations, with shareholders before the meeting to help them make informed decisions.
Market analysts say the move signals Neimeth’s efforts to reinforce its balance sheet and streamline its capital framework amid evolving industry dynamics and funding requirements within Nigeria’s pharmaceutical sector.
Shareholders are urged to participate in the court-ordered meeting, either in person or by proxy, as the outcome will determine the next phase of the company’s restructuring.
Ogochukwu Onwaeze is a writer specializing in business and economic journalism. At THEWILL News Media, she translates market trends, financial developments, and policy shifts into clear and engaging stories.
